Rates of Clostridium difficile infection (CDI) have been on the rise in recent years and this diagnosis can result in significant costs for both individuals and the healthcare system as a whole. Given the recent updated guidelines for CDI, combined with several new agents emerging for this disease, it is critical for healthcare professionals to be aware of the most current research and recommendations for the management of CDI.
RMEI, LLC and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary continuing education virtual lecture titled "Clostridium difficile Infection: Emerging Therapies and Recurrence Prevention" which is certified for physicians, pharmacists and nurses. This activity is supported by an educational grant from Optimer.
Dale Gerding, MD, FACP, FIDSA, professor of medicine at the Stritch School of Medicine at Loyola University Chicago, will serve as moderator for this virtual lecture which was derived from a live symposium held in Boston in October 2011.
Healthcare professionals can visit http://www.rmei.com/ to access this activity.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.